Form 4 for RRX REGAL REXNORD CORP
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0000082811-24-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-29 | 2024-02-27 | RRX | Valentyn Thomas E | EVP, GC, Sec.* | M - OptEx | $133.77 | +5,775 | 34.2K | +20% | +$772.5K |
| D | 2024-02-29 | 2024-02-27 | RRX | Valentyn Thomas E | EVP, GC, Sec.* | F - Tax | $169.12 | -5,128 | 29.1K | -15% | -$867.2K |
| D | 2024-02-29 | 2024-02-27 | RRX | Valentyn Thomas E | EVP, GC, Sec.* | S - Sale+OE | $169.70 | -647 | 28.4K | -2% | -$109.8K |
| D | 2024-02-29 | 2024-02-27 | RRX | Valentyn Thomas E | EVP, GC, Sec.* | M - OptEx | $0.00 | -5,775 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-27 | M | A | 5,775 | $133.77 | 34,187.01 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-27 | F | D | 5,128 | $169.12 | 29,059.01 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-27 | S | D | 647 | $169.70 | 28,412.01 | D | — | — | (F1) The price in Column 4 is a weighted average price. The prices actually received ranged from $169.67 to $170.22. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| 4 | Derivative | Stock Appreciation Rights | 2024-02-27 | M | D | 5,775 | $0.00 | 0 | D | $133.77 · 2022-02-23 to 2031-02-23 | 5,775 Common Stock | (F2) Granted as stock-settled Stock Appreciation Rights ("SARs") under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant. |